Role of biomarkers in pediatric sepsis: What evidence says?
Authors:
- Amit AgrawalAAAmit Agrawal
- Dalwinder JanjuaDJDalwinder Janjua
- Gaurav JadonGJGaurav Jadon
Open Access
- 9 March 2026
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Pediatrics
- Vol. 15 (1)
Abstract
Sepsis is common in hospitalized pediatric patients, leading to increased morbidity, including multiple organ dysfunction and mortality. Fluid resuscitation and antibiotic administration are the primary protective mechanisms for sepsis. However, not all infections are bacterial, and unnecessary antibiotic use increases the risk of developing multidrug resistance; therefore, it is essential to distinguish bacterial from viral or other infections. Routine laboratory investigations cannot always identify the cause of diseases, but assessing different biomarker levels can help identify these infections and treat sepsis accordingly. This mini-review aims to critically analyze the available evidence supporting the use of biomarkers in pediatric sepsis. We have used the search engines PubMed, Cochrane Library, and Google Scholar to retrieve relevant information. We reviewed studies evaluating various biomarkers used for sepsis diagnoses, like C-reactive protein, ferritin, lactate, procalcitonin, tumor necrosis factor-alpha, etc. Apart from the diagnosis, trials are being conducted to assess the role of these biomarkers in monitoring and guiding antibiotic therapy to promote early recovery. The sensitivity of each biological marker varied in different studies, and no single biomarker can identify all types of infections. More robust studies are necessary to compare the roles of various biomarkers in diagnosing and guiding the appropriate therapy.Keywords
This publication has 87 references indexed in Scilit:
- Screening and Identification of Neutrophil Extracellular Trap-related Diagnostic Biomarkers for Pediatric Sepsis by Machine LearningInflammation, 2024
- International Consensus Criteria for Pediatric Sepsis and Septic ShockJAMA, 2024
- Procalcitonin Guided Antibiotic Stewardship in Pediatric Sepsis and Lower Respiratory Tract InfectionsIndian Journal of Pediatrics, 2023
- Combination of C‐reactive protein, procalcitonin, IL‐6, IL‐8, and IL‐10 for early diagnosis of hyperinflammatory state and organ dysfunction in pediatric sepsisJournal of Clinical Laboratory Analysis, 2022
- Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in childrenCochrane Database of Systematic Reviews, 2020
- Updated systematic review and meta‐analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancerPediatric Blood & Cancer, 2019
- Association Between Early Lactate Levels and 30-Day Mortality in Clinically Suspected Sepsis in ChildrenJAMA Pediatrics, 2017
- Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearanceInflammation Research, 2016
- Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive proteinSupportive Care in Cancer, 2013
- Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndromeJournal of Infection and Chemotherapy, 2011